The agreement enables Ambion to adapt its microRNA platforms to detect, quantify, and functionally characterize microRNA sequences discovered by Rosetta. The resulting products will facilitate basic and applied
In the study of more than 5000 patients, the drug was shown to reduce the risk of heart attacks, strokes and death by 16% in high-risk patients with
E1-INT is a short course combination therapy aimed at stimulating the regeneration of the body’s insulin-producing cells, called islet cells. “Expansion into type 2 diabetes significantly broadens the
The initiation of the trial follows an official approval of the study by the Ethical Committee of the Laniado-Sanz Medical Centre in Netanya, Israel. The study is expected
The agreement has been reached under the special protol assessment procedure, a process under which the FDA provides evaluation and guidance on clinical trial protocols for phase III
According to the company, results from the trial provide strong support for clinical investigation, clearly illustrating the prospects for siRNA therapeutics to address unmet clinical need, but also
In exchange, Vical has obtained non-exclusive, sub-licensable rights to use the technology for vaccines against HIV, giving both companies freedom to operate in the field. “These options allow
Patients using the Lilly/Alkermes inhaled insulin system achieved blood sugar levels similar to patients treated with injected insulin. In addition, 80% of patients in this study expressed a
ImClone Systems intends to use the UltiMAb system to develop human antibody product candidates against its disease targets, which are primarily in the area of oncology. Under the
Cytori, in collaboration with researchers from the University of California in Los Angeles, has illustrated that adipose (fat) derived stem and regenerative cells can improve left ventricular function
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.